YorkBridge Wealth Partners’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-534
Closed -$23K 202
2019
Q2
$23K Hold
534
0.01% 450
2019
Q1
$23K Sell
534
-2
-0.4% -$90 0.01% 449
2018
Q4
$24K Hold
536
0.01% 413
2018
Q3
$36K Buy
+536
New +$34.5K 0.02% 390
2018
Q2
Sell
-542
Closed -$26K 843
2018
Q1
$26K Buy
542
+12
+2% +$570 0.01% 457
2017
Q4
$25K Sell
530
-5
-0.9% -$230 0.01% 459
2017
Q3
$24K Hold
535
0.01% 472
2017
Q2
$21K Sell
535
-38
-7% -$1.44K 0.01% 494
2017
Q1
$22K Buy
573
+33
+6% +$1.29K 0.01% 483
2016
Q4
$20K Buy
+540
New +$19.3K 0.01% 473

Other funds holding AVNS

YorkBridge Wealth Partners's AVNS Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 534 shares — an estimated $23K sold.

YorkBridge Wealth Partners first reported a position in AVNS in Q4 2016 and held it in 10 quarters. The position peaked at $36K in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • YorkBridge Wealth Partners reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 534 Avanos Medical shares in Q3 2019, an estimated $23K.
  • YorkBridge Wealth Partners first reported a position in Avanos Medical in Q4 2016 and held it in 10 quarters.
  • YorkBridge Wealth Partners's Avanos Medical position peaked at $36K in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.